1887

Abstract

Genomic regions responsible for the different tissue tropisms of coxsackievirus A9 (CAV9) and coxsackievirus B3 (CBV3) in newborn mice were investigated using recombinant viruses. Infectious cDNA clones of CAV9, a virus known to infect striated muscle, and CBV3, affecting the central nervous system, pancreas, liver, brown fat and striated muscle, were used to generate chimeric viruses. hybridization analysis of different tissues from mice infected with the recombinant viruses, constructed by exchanging the 5′ non-coding region (5′NCR), structural and non-structural genes, demonstrated that the pancreo- and liver tropism map predominantly to CBV3 sequences within the capsid genes, evidently due to receptor recognition. Although the major neurotropism determinant in the CBV3 genome was in the capsid region, viruses containing the CAV9 capsid were also able to initiate infection in the central nervous system provided they contained the CBV3 5′NCR. The presence of the 5′NCR of CAV9 clearly enhanced muscle tissue tropism.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-83-7-1697
2002-07-01
2020-07-02
Loading full text...

Full text loading...

/deliver/fulltext/jgv/83/7/0831697a.html?itemId=/content/journal/jgv/10.1099/0022-1317-83-7-1697&mimeType=html&fmt=ahah

References

  1. Andino R., Böddeker N., Silvera D., Gamarnik A. V.. 1999; Intracellular determinants of picornavirus replication. Trends in Microbiology7:76–82
    [Google Scholar]
  2. Arola A., Kalimo H., Ruuskanen O., Hyypiä T.. 1995; Experimental myocarditis induced by two different coxsackievirus B3 variant: aspects of pathogenesis and comparison of diagnostic methods. Journal of Medical Virology47:251–259
    [Google Scholar]
  3. Bergelson J. M., Mohanty J. G., Crowell R. L., St John N. F., Lublin D. M., Fingerg R. W.. 1995; Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55). Journal of Virology69:1903–1906
    [Google Scholar]
  4. Bergelson J. M., Cunningham J. A., Droguett G., Kurt-Jones E. A., Krithivas A., Hong J. S., Horwitz M. S., Crowell R. L., Finberg R. W.. 1997; Isolation of common receptor for coxsackie B viruses and adenovirus 2 and 5. Science275:1320–1323
    [Google Scholar]
  5. Bergelson J. M., Krithivas A., Celi L., Droguett G., Horwitz M. S., Wickham T., Crowell R. L., Finberg R. W.. 1998; The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses. Journal of Virology72:415–419
    [Google Scholar]
  6. Caggana M., Chan P., Ramsingh A.. 1993; Identification of a single amino acid residue in the capsid protein VP1 of coxsackievirus B4 that determines the virulent phenotype. Journal of Virology67:4797–4803
    [Google Scholar]
  7. Chang K. H., Auvinen P., Hyypiä T., Stanway G.. 1989; The nucleotide sequence of coxsackievirus A9 – implication for receptor binding and enterovirus classification. Journal of General Virology70:3269–3280
    [Google Scholar]
  8. Chapman N. M., Ragland A., Leser J. S., Höfling K., Willian S., Semler B. L., Tracy S.. 2000; A group B coxsackievirus/poliovirus 5′ nontranslated region chimera can act as an attenuated vaccine strain in mice. Journal of Virology74:4047–4056
    [Google Scholar]
  9. Dalldorf G., Melnick J. L.. 1965; Coxsackieviruses. In Viral and Rickettsial Infections on Man pp472–512 Edited by Horsfall F. L., Tamm I.. Philadelphia: Lippincott;
    [Google Scholar]
  10. Dunn J. J., Chapman N. M., Tracy S., Romero J. R.. 2000; Genomic determinants of cardiovirulence in coxsackievirus B3 clinical isolates: localization to the 5′ nontranslated region. Journal of Virology74:4787–4794
    [Google Scholar]
  11. Evans D. M. A., Dunn G., Minor P. D., Schild G. C., Cann A. J., Stanway G., Almond J. W., Currey K., Maizel J. V.. 1985; A single nucleotide change in the 5′ non-coding region of the genome of the Sabin type 3 poliovaccine is associated with increased neurovirulence. Nature314:548–550
    [Google Scholar]
  12. Evans J. D., Almond W. J.. 1998; Cell receptors for picornaviruses as determinants of cell tropism and pathogenesis. Trends in Microbiology6:198–202
    [Google Scholar]
  13. Freistadt M. S., Fleit H. B., Wimmer E.. 1993; Poliovirus receptor on human blood cells: a possible extraneural site of poliovirus replication. Virology195:798–803
    [Google Scholar]
  14. Gamarnik A. V., Andino R.. 2000; Interactions of viral protein 3CD and poly(rC) binding protein with the 5′ untranslated region of the poliovirus genome. Journal of Virology74:2219–2226
    [Google Scholar]
  15. Grist N. R., Bell E. J., Assaad F.. 1978; Enteroviruses in human disease. Progress in Medical Virology24:114–157
    [Google Scholar]
  16. Gromeier M., Bossert B., Arita M., Nomoto A., Wimmer E.. 1999; Dual stem loops within the poliovirus internal ribosomal entry site control neurovirulence. Journal of Virology73:958–964
    [Google Scholar]
  17. Gromeier M., Solecki D., Patel D. D., Wimmer E.. 2000; Expression of the human poliovirus receptor/CD155 gene during development of the central nervous system: implications for the pathogenesis of poliomyelitis. Virology273:248–257
    [Google Scholar]
  18. Hovi T., Stenvik M., Rosenlew M.. 1996; Relative abundance of enterovirus serotypes in sewage differs from that in patients: clinical and epidemiological implications. Epidemiology and Infection116:91–97
    [Google Scholar]
  19. Hughes P., Horsnell C., Hyypiä T., Stanway G.. 1995; The coxsackievirus A9 RGD motif is not essential for virus viability. Journal of Virology69:8035–8040
    [Google Scholar]
  20. Hyypiä T., Kallajoki M., Maaronen M., Stanway G., Kandolf R., Auvinen P., Kalimo H.. 1993; Pathogenetic differences between coxsackie A and B virus infections in newborn mice. Virus Research27:71–78
    [Google Scholar]
  21. Hyypiä T., Hovi T., Knowles N. J., Stanway G.. 1997; Classification of enteroviruses based on molecular and biological properties. Journal of General Virology78:1–11
    [Google Scholar]
  22. Kandolf R., Hofschneider P. H.. 1985; Molecular cloning of the genome of a cardiotropic coxsackie B3 virus: full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells. Proceedings of the National Academy of Sciences, USA82:4818–4822
    [Google Scholar]
  23. King A. M. Q., Brown F., Christian P., Hovi T., Hyypiä T., Knowles N. J., Lemon S. P., Minor P. D., Palmenberg A. C., Skern T., Stanway G.. 2000; Picornaviridae. In Virus taxonomy. Seventh Report of the International Committee on Taxonomy of Viruses pp657–673 Edited by van Regenmortel M. H. V., Fauquet C. M., Bishop D. H. L., Carstens E. B., Estes M. K., Lemon S. M., Maniloff J., Mayo M. A., McGeoch D. J., Pringle C. R., Wickner R. B.. San Diego: Academic Press;
    [Google Scholar]
  24. Klump W. M., Bergmann I., Muller B. C., Ameis D., Kandolf R.. 1990; Complete nucleotide sequence of infectious coxsackievirus B3 cDNA: two initial 5′ uridine residues are regained during plus-strand RNA synthesis. Journal of Virology64:1573–1583
    [Google Scholar]
  25. Knowlton K. U., Jeon E. S., Berkley N., Wessely R., Huber S.. 1996; A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3. Journal of Virology70:7811–7818
    [Google Scholar]
  26. Koike S., Taya S., Kurata T., Abe S., Ise I., Yonekawa H., Nomoto A.. 1991; Transgenic mice susceptible to poliovirus. Proceedings of the National Academy of Sciences, USA88:951–955
    [Google Scholar]
  27. Lindberg A. M., Crowell R. L., Zell R., Kandolf R., Petterson U.. 1992; Mapping of the RD phenotype of the Nancy strain of coxsackievirus B3. Virus Research24:187–196
    [Google Scholar]
  28. Mena I., Fischer C., Gebhard J. R., Perry C. M., Harkins S., Whitton J. L.. 2000; Coxsackievirus infection of the pancreas: evaluation of receptor expression, pathogenesis, and immunopathology. Virology271:276–288
    [Google Scholar]
  29. Minor D. P.. 1992; The molecular biology of poliovaccines. Journal of Virology73:3065–3077
    [Google Scholar]
  30. Moore M., Morens D. M.. 1984; Enteroviruses, including polioviruses. In Textbook of Virology pp407–483 Edited by Belshe R. B.. Massachusetts: PGS Publishing Company;
    [Google Scholar]
  31. Pulli T., Koskimies P., Hyypiä T.. 1995; Molecular comparison of coxsackie A virus serotypes. Virology212:30–38
    [Google Scholar]
  32. Ramsingh A., Collins D. N.. 1995; A point mutation in the VP4 coding sequence of coxsackievirus B4 influences virulence. Journal of Virology69:7278–7281
    [Google Scholar]
  33. Ren R., Racaniello V.. 1992; Human poliovirus receptor gene expression and poliovirus tissue tropism in transgenic mice. Journal of Virology66:296–304
    [Google Scholar]
  34. Ren R., Constantini F., Gorgacz E. J., Lee J. J., Racaniello V. R.. 1990; Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis. Cell63:353–362
    [Google Scholar]
  35. Ren R., Ross E. G., Racaniello V. R.. 1991; Identification of two determinants that attenuate vaccine-related type 2 poliovirus. Journal of Virology65:1377–1380
    [Google Scholar]
  36. Rinehart J. E., Gómez R. M., Roos R. P.. 1997; Molecular determinants for virulence in coxsackievirus B1 infection. Journal of Virology71:3986–3991
    [Google Scholar]
  37. Roivainen M., Hyypiä T., Piirainen L., Kalkkinen N., Stanway G., Hovi T.. 1991; RGD-dependent entry of coxsackievirus A9 into host cell and its bypass after cleavage of VP1 protein by intestinal proteases. Journal of Virology65:4735–4740
    [Google Scholar]
  38. Roivainen M., Piirainen L., Hovi T., Virtanen I., Riikonen T., Heino J., Hyypiä T.. 1994; Entry of coxsackievirus A9 into host cells: specific interactions with αvβ3 integrin, the virtonectin receptor. Virology203:357–365
    [Google Scholar]
  39. Santti J., Hyypiä T., Kinnunen L., Salminen M.. 1999; Evidence of recombination among enteroviruses. Journal of Virology73:8741–8749
    [Google Scholar]
  40. Santti J., Harvala H., Kinnunen L., Hyypiä T.. 2000; Molecular epidemiology and evolution of coxsackievirus A9. Journal of General Virology81:1361–1372
    [Google Scholar]
  41. Schmidtke M., Selinka H. C., Heim A., Jahn B., Tonew M., Kandolf R., Stelzner A., Zell R.. 2000; Attachment of coxsackievirus B3 variants to various cell lines: mapping of phenotype differences to capsid protein VP1. Virology275:77–88
    [Google Scholar]
  42. Svitkin Y. V., Cammack N., Minor P. D., Almond J.. 1990; Translation deficiency of the Sabin type 3 poliovirus genome: association with an attenuating mutation C472→U. Virology175:103–109
    [Google Scholar]
  43. Tu Z., Chapman N. M., Hufnagel G., Tracy S., Romero J. R., Barry W. H., Zhao L., Currey K., Shapiro B.. 1995; The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5′ nontranslated region. Journal of Virology69:4607–4618
    [Google Scholar]
  44. Waris M., Ziegler T., Kivivirta M., Ruuskanen O.. 1990; Rapid detection of respiratory syncytial virus and influenza A virus in cell cultures by immunoperoxidase staining with monoclonal antibodies. Journal of Clinical Microbiology28:1159–1162
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-83-7-1697
Loading
/content/journal/jgv/10.1099/0022-1317-83-7-1697
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error